New drug aims to stop chemo hair loss in its tracks
NCT ID NCT07397325
First seen Feb 10, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study tests a new treatment called DA-020 to prevent hair loss in people with early-stage breast cancer who are about to start chemotherapy. The study will include 60 adults aged 18 to 65. Researchers will measure how much hair is lost during treatment and how well hair grows back afterward.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY INDUCED ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Samel
Manaus, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Rome ("G. Marconi")
Rome, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.